Marilyn K Glassberg

5PUBLICATIONS
29CO-AUTHORS
Life cycle assessment and industrial ecologyGene expression (incl. microarray and other genome-wide approaches)Pharmacology and pharmaceutical sciences not elsewhere classifiedRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 02, 2025
Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease.

Kerri A Johannson, Ayodeji Adegunsoye, Jürgen Behr

|Apr 04, 2024
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.

Ayodeji Adegunsoye, Jonathan A Kropski, Juergen Behr

|Jun 30, 2023
Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies.

Jürgen Behr, Steven D Nathan, Ulrich Costabel

|Feb 26, 2021
Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease.

Michael F Morris, Yash Pershad, Paul Kang

|Oct 03, 2020
Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis.

Toby M Maher, Ulrich Costabel, Marilyn K Glassberg

Pageof 1

Frequent Collaborators

2 joint publications

Ulrich Costabel

2 joint publications

Ayodeji Adegunsoye

2 joint publications

Kerri A Johannson

2 joint publications

Jürgen Behr